In Vitro & In Vivo Diagnostic Substances Industry - Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	oc	Own	H
11/19/24 16:39	11/15/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Marshall Robert J. Jr.	MA	O	CFO,Trea	4	S	-3,480	69.59	-50		114	D
11/18/24 17:36	11/14/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Blanchfield Paul	MA	O	P	6	S	-1,695	66.67	-25		103	D
11/12/24 17:41	11/8/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Heino Mary Anne	MA	D		5	S	-9,634	69.53	-139		708	D
10/11/24 17:23	10/11/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Diaz Paul J	UT	DO	P,CEO	3	S.m	-6,474	25.11	-258		1,066	D
10/4/24 17:29	10/2/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Dube Michael P	MA	O	VP,Chief	1	S	-38	19.01	-2		47	D
9/12/24 16:09	9/11/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Muzzey Dale	UT	O	Chief Sc	1	S	-55	26.17	-2		108	D
9/9/24 17:48	9/9/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Dreismann Heinrich	UT	D		1	S	-271	27.05	-10		122	D
9/4/24 21:13	2/2/24	IONS	Ionis Pharmaceuticals Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Hougen Elizabeth L	CA	O	EVP,Fina	3	S.d	-650	50.13	-13		93	D
9/4/24 19:38	9/3/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Reitan Colleen F	UT	D		1	S	-1,286	27.95	-46		43	D
8/23/24 16:30	8/21/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Thrall James H	MA	D		1	S	-99	98.52	-1		34	D
8/23/24 16:16	8/21/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Ancona Margaret	UT	O	SVP,Chie	1	S	-321	27.82	-12		79	D
8/20/24 16:38	8/19/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Kumar Rashmi	UT	D		1	S	-210	28.01	-8		77	D
8/16/24 16:30	8/14/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Niedzwiecki Daniel	MA	O	See Rema	4	S.d	-1,753	77.85	-23		80	D
8/14/24 16:56	8/12/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Ber Gerard	MA	D		1	S	-1,495	96.48	-16		21	D
7/17/24 16:30	7/15/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Sabens Andrea	MA	O	Chief Ac	10	S.m	-606	91.58	-7		63	D
7/12/24 16:30	7/10/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Pruden Gary J	MA	D		1	S	-1,191	95.04	-13		23	I
7/3/24 13:15	7/1/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	3	S.d	-165	29.41	-6		71	D
6/20/24 17:00	6/17/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Verwiel Frank	MA	D		1	S	-38	25.00	-2		18	D
6/18/24 16:05	6/14/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Martin Samuel Bates	NJ	O	SVP,CFO	2	S.d	-1,800	34.50	-52		28	D
6/18/24 16:04	6/14/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Crowley Elizabeth	NJ	O	SVP,CPDO	3	S.d	-2,870	34.33	-84		9	D
6/11/24 16:01	6/7/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Young Diane C.	NJ	O	SVP,Chie	1	S	-1,587	35.26	-45		2	D
6/5/24 16:06	6/3/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Heath-Chiozzi Margo	NJ	O	SVP of R	2	S.d	-3,283	33.82	-97		13	D
6/5/24 16:05	6/3/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Wright Richard M.	NJ	O	SVP,CCO	1	S.d	-1,579	33.72	-47		21	D
6/5/24 16:04	6/3/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Jimenez Freddy A.	NJ	O	SVP,GC	1	S.d	-269	33.60	-8		26	D
6/4/24 17:57	6/3/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		1	S.m	-167	22.05	-8		33	D
6/3/24 16:04	5/30/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cavanaugh Sarah	NJ	O	SVP of C	1	S.d	-703	33.73	-21		2	D
5/30/24 16:34	5/28/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Maeusli Heinz Christoph	MA	D		1	S.d	-1,455	79.19	-18		23	D
5/30/24 16:32	5/28/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	McHugh Julie	MA	D		1	S	-196	78.50	-3		29	D
5/20/24 17:00	5/17/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Claflin Bruce L.	ME	D		1	S	-108	540.80	0		2	D
5/15/24 17:48	5/13/24	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Newcomer Lee Nisley	UT	D		1	S	-157	25.30	-6		67	D
3/7/24 17:00	3/6/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Polewaczyk James F	ME	O	EVP	3	S.d	-22,294	522.72	-43		11	D
3/7/24 17:00	3/5/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Vandebroek Sophie V.	ME	D		1	S.d	-790	562.98	-1		9	D
3/7/24 16:30	3/5/24	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Leno Sam R	MA	D		2	S.dm	-1,727	65.21	-26		58	D
3/5/24 16:10	3/4/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Basta James	MA	O	EVP,GC	2	S.d	-188	30.79	-6		82	D
2/9/24 17:03	2/8/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Fennell George	ME	O	SVP,Chie	1	S.d	-4,705	573.87	-8		7	D
2/9/24 17:01	2/7/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	McKeon Brian P	ME	O	EVP,CFO,	1	S.d	-13,296	570.01	-23		48	D
2/9/24 17:00	2/7/24	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Mazelsky Jonathan Jay	ME	DO	P,CEO	3	S.d	-17,402	534.58	-33		79	D
1/10/24 16:15	1/8/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	2	S	-229	29.29	-8		46	D
1/5/24 16:51	1/3/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	1	S	-566	29.46	-19		905	D
1/5/24 16:50	1/3/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	1	S	-172	29.46	-6		54	D
1/5/24 16:49	1/3/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	1	S	-158	29.46	-5		41	D
1/5/24 16:46	1/3/24	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Hicks Derek	MA	O	EVP,Chie	1	S	-114	29.46	-4		37	D
1/3/24 10:41	1/2/24	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Eight Corp Ltd	Y8	T		2	S	-33	0.8250	-40	0	12,025	I
12/8/23 17:28	12/6/23	AWH	Aspira Women'S Health Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Merchant Minh Hoang	TX	O	Secretar	1	S	-3	3.37	-1		27	I
12/5/23 16:19	12/1/23	MYGN	Myriad Genetics Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	2	S	-1,043	17.39	-60		322	D
11/2/23 16:42	10/31/23	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Bhanji Muna	MA	D		3	S	-91	37.93	-2		13	D
10/17/23 10:06	10/13/23	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Lilly Jason Warren	MI	O	VP	2	S	-35	15.60	-2		27	D
10/13/23 17:03	6/2/23	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Baylor-Henry Minnie	MA	D		1	S	-1	86.17	0		0	I
10/12/23 11:54	10/11/23	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		2	S.d	-74	18.17	-4		25	D
8/17/23 19:37	8/15/23	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Ayers Jonathan W	ME	D		1	S	0	0.00	0	0	596	D
8/7/23 17:04	8/3/23	IDXX	Idexx Laboratories Inc /de	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Lane Michael	ME	O	EVP	1	S.d	-8,174	510.00	-16		5	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y